ERβ as Mediator of Estrogen Signaling in Inflammatory Breast Cancer | Oncotarget

Oncotarget published this editorial on June 12, 2023 in Volume 14, entitled, “ERβ as Mediator of Estrogen Signaling in Inflammatory Breast Cancer" by Harika Nagandla and Christoforos Thomas from the Houston Methodist Research Institute, Houston Methodist Neal Cancer Center, Houston, TX. @HoustonMethodist
#cancer #breastcancer #ibc #metastasis #cancerresearch #research #editorial #openaccess #openscience #peerreview #journal #publication #meded #publishing

DOI - https://doi.org/10.18632/oncotarget.28425

Correspondence to - Christoforos Thomas - cthomas3@houstonmethodist.org

Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.c....om/details/email_upd

Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/

Keywords - inflammatory breast cancer, IBC, ERβ, metastasis, actin based cell migration

About Oncotarget

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form, and then quickly released to Pubmed. On September 15, 2022, Oncotarget was accepted again for indexing by MEDLINE. Oncotarget is now indexed by Medline/PubMed and PMC/PubMed.

To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957